SMITHKLINE BEECHAM IS GOING INTO PBM BUSINESS VIA $2.3 BIL. PURCHASE OF DPS: HMO NICHE OF BUSINESS MAY OFFER CONTROL ADVANTAGE COMPARED TO MEDCO/PAID
Executive Summary
SmithKline Beecham is following the Merck vertical integration strategy, but for less than half the investment SB has found a pharmacy benefit manager that has established its position in a separate niche -- with the potential for more control over the drug choices for the covered lives.